Author
The author works as a Correspondent with BW Businessworld
Zydus Lifesciences net profit for the quarter was recorded at Rs 522.5 crores against Rs 3,002 crores registered in the second quarter of the last year
Read More
Apollo Hospitals in the second quarter has reported a dip of 21.47 per cent in its net profit of Rs 204 crores against its net profit of Rs 247.8 crores in the corresponding quarter last year
Read More
Lupin pharma has posted a net profit of Rs 134.5 crores in quarter two of the fiscal year 2023, compared with a loss of 2,094.9 crores in the corresponding quarter last year
Read More
In an exclusive interaction with BW Healthcare World, Sriram Natarajan, Director, Molbio Diagnostics speaks on the overhaul of the company after the pandemic, investment by Temasek, Truenat technology and its market, India's fight against tuberculosis and the company's future plans
Read More
Piramal Pharma, an Indian pharmaceuticals company, today announced its consolidated results for the Second Quarter and Half Year ended 30th September 2022. The pharma company in the second quarter has reported a net loss of Rs 37 crores in its first quarterly results after getting listed on BSE
Read More
The diagnostic company has posted a 24.8 per cent drop in its net profit of Rs 72.4 crores for Quarter Two of the Financial Year 2022 (Q2FY22), from Rs 96.3 crores that the company secured in the same quarter last year
Read More
The company also registered an 18.48 per cent drop in its net profit in the second quarter to be recorded at Rs 494 crores as against its earnings in the same quarter last year which stood at Rs 606 crores
Read More
The pharmaceutical company’s net profit also jumped by 10.91 per cent quarter on quarter in Q2FY22, the company recorded a net profit of Rs 788.90 crores in the September quarter
Read More
EBITDA earnings for Q2FY23 of the hospital also soared with a quarter-on-quarter increase of 34.99 per cent and stood at Rs 109.5 crores up from Rs 89.2 crores in the second quarter last year
Read More
The company’s sales in India were recorded at Rs 3,460 crore, a rise of 8.5 per cent against the second quarter of last year. At the same time, the sales in the US were up by 27.5 per cent quarter on quarter and stood at USD 200 million
Read More
